GPER-novel membrane oestrogen receptor.

The recent discovery of the G protein-coupled oestrogen receptor (GPER) presents new challenges and opportunities for understanding the physiology, pathophysiology and pharmacology of many diseases. This review will focus on the expression and function of GPER in hypertension, kidney disease, atherosclerosis, vascular remodelling, heart failure, reproduction, metabolic disorders, cancer, environmental health and menopause. Furthermore, this review will highlight the potential of GPER as a therapeutic target.

[1]  C. Rosano,et al.  Recent Advances on the Role of G Protein-Coupled Receptors in Hypoxia-Mediated Signaling , 2016, The AAPS Journal.

[2]  Takeshi Kimura,et al.  Influence of Sex on Long-Term Outcomes After Implantation of Bare-Metal Stent: A Multicenter Report From the Coronary Revascularization Demonstrating Outcome Study-Kyoto (CREDO-Kyoto) Registry Cohort-1 , 2015, Circulation.

[3]  R. Feldman,et al.  Copernicus Revisited: Overturning Ptolemy's View of the GPER Universe , 2015, Trends in Endocrinology & Metabolism.

[4]  E. Prossnitz,et al.  G protein-coupled estrogen receptor inhibits vascular prostanoid production and activity. , 2015, The Journal of endocrinology.

[5]  A. Belfiore,et al.  Copper activates HIF-1α/GPER/VEGF signalling in cancer cells , 2015, Oncotarget.

[6]  E. Prossnitz,et al.  What have we learned about GPER function in physiology and disease from knockout mice? , 2015, The Journal of Steroid Biochemistry and Molecular Biology.

[7]  F. Lumachi,et al.  Current medical treatment of estrogen receptor-positive breast cancer. , 2015, World journal of biological chemistry.

[8]  Feng Guo,et al.  Nonylphenol affects myocardial contractility and L-type Ca(2+) channel currents in a non-monotonic manner via G protein-coupled receptor 30. , 2015, Toxicology.

[9]  C. Pearl,et al.  Immunolocalization of G protein-coupled estrogen receptor in the rat epididymis , 2015, Reproductive Biology and Endocrinology.

[10]  M. Pellegrino,et al.  Estrogenic gper signaling regulates mir144 expression in cancer cells and cancer-associated fibroblasts (cafs) , 2015, Oncotarget.

[11]  Hao Wang,et al.  Activation of GPR30 inhibits cardiac fibroblast proliferation , 2015, Molecular and Cellular Biochemistry.

[12]  E. Prossnitz,et al.  Emerging roles of GPER in diabetes and atherosclerosis , 2015, Trends in Endocrinology & Metabolism.

[13]  Hao Wang,et al.  GPR30 decreases cardiac chymase/angiotensin II by inhibiting local mast cell number. , 2015, Biochemical and biophysical research communications.

[14]  R. Tostes,et al.  Diabetes impairs the vascular effects of aldosterone mediated by G protein-coupled estrogen receptor activation , 2015, Front. Pharmacol..

[15]  N. Nass,et al.  Tamoxifen resistance: from cell culture experiments towards novel biomarkers. , 2015, Pathology, research and practice.

[16]  S. Belcher,et al.  Bisphenol A alters autonomic tone and extracellular matrix structure and induces sex-specific effects on cardiovascular function in male and female CD-1 mice. , 2015, Endocrinology.

[17]  E. Prossnitz,et al.  Effects of Atrazine on Estrogen Receptor α– and G Protein–Coupled Receptor 30–Mediated Signaling and Proliferation in Cancer Cells and Cancer-Associated Fibroblasts , 2015, Environmental health perspectives.

[18]  E. Prossnitz,et al.  G Protein-coupled Estrogen Receptor Protects from Atherosclerosis , 2014, Scientific Reports.

[19]  R. Hegele,et al.  A common hypofunctional genetic variant of GPER is associated with increased blood pressure in women. , 2014, British journal of clinical pharmacology.

[20]  Zhuojia Chen,et al.  The activation of G protein-coupled receptor 30 (GPR30) inhibits proliferation of estrogen receptor-negative breast cancer cells in vitro and in vivo , 2014, Cell Death and Disease.

[21]  Kaifeng Qiu,et al.  Bisphenol A stimulates human lung cancer cell migration via upregulation of matrix metalloproteinases by GPER/EGFR/ERK1/2 signal pathway. , 2014, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[22]  H. Urbanski,et al.  Expression of the oestrogen receptor GPER by testicular peritubular cells is linked to sexual maturation and male fertility , 2014, Andrology.

[23]  J. Morrison,et al.  G-protein coupled estrogen receptor, estrogen receptor α, and progesterone receptor immunohistochemistry in the hypothalamus of aging female rhesus macaques given long-term estradiol treatment. , 2014, Journal of experimental zoology. Part A, Ecological genetics and physiology.

[24]  A. Wójtowicz,et al.  Isomer-nonspecific action of dichlorodiphenyltrichloroethane on aryl hydrocarbon receptor and G-protein-coupled receptor 30 intracellular signaling in apoptotic neuronal cells , 2014, Molecular and Cellular Endocrinology.

[25]  M. Díaz-Zaragoza,et al.  Mechanisms associated with resistance to tamoxifen in estrogen receptor-positive breast cancer (review). , 2014, Oncology reports.

[26]  B. Olde,et al.  G protein-coupled Receptor 30 (GPR30) Forms a Plasma Membrane Complex with Membrane-associated Guanylate Kinases (MAGUKs) and Protein Kinase A-anchoring Protein 5 (AKAP5) That Constitutively Inhibits cAMP Production* , 2014, The Journal of Biological Chemistry.

[27]  S. Fuqua,et al.  Tamoxifen through GPER upregulates aromatase expression: a novel mechanism sustaining tamoxifen-resistant breast cancer cell growth , 2014, Breast Cancer Research and Treatment.

[28]  T. Simoncini,et al.  Vasodilatory effects of the selective GPER agonist G-1 is maximal in arteries of postmenopausal women. , 2014, Maturitas.

[29]  H. Aisa,et al.  Icariin and icaritin stimulate the proliferation of SKBr3 cells through the GPER1-mediated modulation of the EGFR-MAPK signaling pathway. , 2014, International journal of molecular medicine.

[30]  D. Clegg,et al.  Sexually dimorphic role of G protein-coupled estrogen receptor (GPER) in modulating energy homeostasis , 2014, Hormones and Behavior.

[31]  S. Oparil,et al.  Estrogen Effects on Vascular Inflammation Are Age Dependent: Role of Estrogen Receptors , 2014, Arteriosclerosis, thrombosis, and vascular biology.

[32]  E. Prossnitz,et al.  Estrogen biology: New insights into GPER function and clinical opportunities , 2014, Molecular and Cellular Endocrinology.

[33]  M. Alves,et al.  Expression pattern of G protein-coupled receptor 30 in human seminiferous tubular cells. , 2014, General and comparative endocrinology.

[34]  M. Maggiolini,et al.  GPER Function in Breast Cancer: An Overview , 2014, Front. Endocrinol..

[35]  U. Kintscher,et al.  Sex- and age-dependent effects of Gpr30 genetic deletion on the metabolic and cardiovascular profiles of diet-induced obese mice. , 2014, Gene.

[36]  E. Prossnitz,et al.  Activation of GPER-1 Estradiol Receptor Downregulates Production of Testosterone in Isolated Rat Leydig Cells and Adult Human Testis , 2014, PloS one.

[37]  H. Liu,et al.  Involvement of activating ERK1/2 through G protein coupled receptor 30 and estrogen receptor α/β in low doses of bisphenol A promoting growth of Sertoli TM4 cells. , 2014, Toxicology letters.

[38]  Hao Wang,et al.  Role of estrogen in diastolic dysfunction. , 2014, American journal of physiology. Heart and circulatory physiology.

[39]  T. Arumugam,et al.  Sex-Dependent Effects of G Protein–Coupled Estrogen Receptor Activity on Outcome After Ischemic Stroke , 2014, Stroke.

[40]  M. Chappell,et al.  Vasodilation by GPER in mesenteric arteries involves both endothelial nitric oxide and smooth muscle cAMP signaling , 2014, Steroids.

[41]  M. Hixon,et al.  Anatomical location and redistribution of G protein-coupled estrogen receptor-1 during the estrus cycle in mouse kidney and specific binding to estrogens but not aldosterone , 2014, Molecular and Cellular Endocrinology.

[42]  A. Noske,et al.  The G Protein-Coupled Estrogen Receptor (GPER) Is Expressed in Two Different Subcellular Localizations Reflecting Distinct Tumor Properties in Breast Cancer , 2014, PloS one.

[43]  M. Taggart,et al.  Human uterine and placental arteries exhibit tissue-specific acute responses to 17β-estradiol and estrogen-receptor-specific agonists , 2013, Molecular human reproduction.

[44]  E. Prossnitz,et al.  G Protein-Coupled Estrogen Receptor-Selective Ligands Modulate Endometrial Tumor Growth , 2013, Obstetrics and gynecology international.

[45]  J. Reckelhoff,et al.  Sex and gender differences in control of blood pressure. , 2013, Clinical science.

[46]  K. Dedes,et al.  Histone deacetylase inhibitors down-regulate G-protein-coupled estrogen receptor and the GPER-antagonist G-15 inhibits proliferation in endometriotic cells. , 2013, Fertility and sterility.

[47]  I. Perrotta,et al.  The nuclear localization signal is required for nuclear GPER translocation and function in breast Cancer-Associated Fibroblasts (CAFs) , 2013, Molecular and Cellular Endocrinology.

[48]  E. Prossnitz,et al.  GPER deficiency in male mice results in insulin resistance, dyslipidemia, and a proinflammatory state. , 2013, Endocrinology.

[49]  M. Chappell,et al.  Reduced vasorelaxation to estradiol and G-1 in aged female and adult male rats is associated with GPR30 downregulation. , 2013, American journal of physiology. Endocrinology and metabolism.

[50]  R. Khalil,et al.  Subtype-specific Estrogen Receptor-mediated Vasodilator Activity in the Cephalic, Thoracic, and Abdominal Vasculature of Female Rat , 2013, Journal of cardiovascular pharmacology.

[51]  Richard E. White,et al.  Activation of GPER Induces Differentiation and Inhibition of Coronary Artery Smooth Muscle Cell Proliferation , 2013, PloS one.

[52]  A. Roessner,et al.  GPER-1 Expression Decreases During Breast Cancer Tumorigenesis , 2013, Cancer investigation.

[53]  R. Feldman,et al.  Aldosterone mediates its rapid effects in vascular endothelial cells through GPER activation. , 2013, American journal of physiology. Cell physiology.

[54]  Tudor I. Oprea,et al.  Bradycardic effects mediated by activation of G protein‐coupled estrogen receptor in rat nucleus ambiguus , 2013, Experimental physiology.

[55]  A. Kurt,et al.  Vasoconstriction induced by G1, a G-protein-coupled oestrogen receptor1 (GPER-1) agonist, in the isolated perfused rat kidney. , 2013, European journal of pharmacology.

[56]  Ben-Zhan Zhu,et al.  Bisphenol A at a low concentration boosts mouse spermatogonial cell proliferation by inducing the G protein-coupled receptor 30 expression. , 2013, Toxicology and applied pharmacology.

[57]  C. Klinge,et al.  Enhanced expression of G-protein coupled estrogen receptor (GPER/GPR30) in lung cancer , 2012, BMC Cancer.

[58]  S. Davidge,et al.  G-Protein Coupled Receptor 30 (GPR30): A Novel Regulator of Endothelial Inflammation , 2012, PloS one.

[59]  S. Liu,et al.  Oestrogens improve human pancreatic islet transplantation in a mouse model of insulin deficient diabetes , 2012, Diabetologia.

[60]  Dongye Li,et al.  Chronic Activation of the G Protein-Coupled Receptor 30 with Agonist G-1 Attenuates Heart Failure , 2012, PloS one.

[61]  E. Prossnitz,et al.  GPER regulates endothelin-dependent vascular tone and intracellular calcium. , 2012, Life sciences.

[62]  R. Komers,et al.  Estrogen protects renal endothelial barrier function from ischemia-reperfusion in vitro and in vivo. , 2012, American journal of physiology. Renal physiology.

[63]  P. Thomas,et al.  Role of ERβ and GPR30 in the endocrine pancreas: A matter of estrogen dose , 2012, Steroids.

[64]  F. Liu,et al.  Genistein regulates the IL-1 beta induced activation of MAPKs in human periodontal ligament cells through G protein-coupled receptor 30. , 2012, Archives of biochemistry and biophysics.

[65]  Hao Wang,et al.  Activation of GPR30 attenuates diastolic dysfunction and left ventricle remodelling in oophorectomized mRen2.Lewis rats. , 2012, Cardiovascular research.

[66]  B. Olde,et al.  The G protein-coupled oestrogen receptor 1 agonist G-1 disrupts endothelial cell microtubule structure in a receptor-independent manner , 2012, Molecular and Cellular Biochemistry.

[67]  Robert N. Taylor,et al.  G Protein-Coupled Estrogen Receptor (GPER) Expression in Normal and Abnormal Endometrium , 2012, Reproductive Sciences.

[68]  F. Mauvais-Jarvis,et al.  Importance of oestrogen receptors to preserve functional β-cell mass in diabetes , 2012, Nature Reviews Endocrinology.

[69]  E. Prossnitz,et al.  Deletion of G Protein–Coupled Estrogen Receptor Increases Endothelial Vasoconstriction , 2012, Hypertension.

[70]  V. Holcomb,et al.  Oestrogen alters adipocyte biology and protects female mice from adipocyte inflammation and insulin resistance , 2012, Diabetes, obesity & metabolism.

[71]  Richard E. White,et al.  Activation of G protein-coupled estrogen receptor induces endothelium-independent relaxation of coronary artery smooth muscle. , 2011, American journal of physiology. Endocrinology and metabolism.

[72]  Tudor I. Oprea,et al.  G protein-coupled estrogen receptor 1-mediated effects in the rat myometrium. , 2011, American journal of physiology. Cell physiology.

[73]  Tudor I. Oprea,et al.  Identification of a GPER/GPR30 antagonist with improved estrogen receptor counterselectivity , 2011, The Journal of Steroid Biochemistry and Molecular Biology.

[74]  B. Borlaug,et al.  Why are women more likely than men to develop heart failure with preserved ejection fraction? , 2011, Current opinion in cardiology.

[75]  M. Chappell,et al.  Estrogen Receptor GPR30 Reduces Oxidative Stress and Proteinuria in the Salt-Sensitive Female mRen2.Lewis Rat , 2011, Hypertension.

[76]  D. Clegg,et al.  Obesity, insulin resistance and diabetes: sex differences and role of oestrogen receptors , 2011, Acta physiologica.

[77]  Ben-Zhan Zhu,et al.  Low Concentrations of Bisphenol A Induce Mouse Spermatogonial Cell Proliferation by G Protein–Coupled Receptor 30 and Estrogen Receptor-α , 2011, Environmental health perspectives.

[78]  E. Filardo,et al.  Retrograde transport of the transmembrane estrogen receptor, G-protein-coupled-receptor-30 (GPR30/GPER) from the plasma membrane towards the nucleus , 2011, Steroids.

[79]  E. Prossnitz,et al.  The G protein-coupled estrogen receptor GPER/GPR30 as a regulator of cardiovascular function. , 2011, Vascular pharmacology.

[80]  E. Prossnitz,et al.  Mechanisms of estradiol-induced insulin secretion by the G protein-coupled estrogen receptor GPR30/GPER in pancreatic beta-cells. , 2011, Endocrinology.

[81]  E. Prossnitz,et al.  Vasodilation in Response to the GPR30 Agonist G-1 is Not Different From Estradiol in the mRen2.Lewis Female Rat , 2011, Journal of cardiovascular pharmacology.

[82]  R. Kumar,et al.  Insulinotropic and antidiabetic effects of 17β-estradiol and the GPR30 agonist G-1 on human pancreatic islets. , 2011, Endocrinology.

[83]  R. Smith,et al.  G-1-activated membrane estrogen receptors mediate increased contractility of the human myometrium. , 2011, Endocrinology.

[84]  S. Das,et al.  GPR30 activation opposes estrogen-dependent uterine growth via inhibition of stromal ERK1/2 and estrogen receptor alpha (ERα) phosphorylation signals. , 2011, Endocrinology.

[85]  S. Andò,et al.  The G Protein-coupled Receptor 30 Is Up-regulated by Hypoxia-inducible Factor-1α (HIF-1α) in Breast Cancer Cells and Cardiomyocytes* , 2011, The Journal of Biological Chemistry.

[86]  Hao Wang,et al.  Attenuation of Salt-Induced Cardiac Remodeling and Diastolic Dysfunction by the GPER Agonist G-1 in Female mRen2.Lewis Rats , 2010, PloS one.

[87]  I. Marriott,et al.  GPR30/GPER-1 mediates rapid decreases in TLR4 expression on murine macrophages , 2010, Molecular and Cellular Endocrinology.

[88]  A. Ehinger,et al.  G protein-coupled estrogen receptor 1 (GPER, GPR 30) in normal human endometrium and early pregnancy decidua. , 2010, Molecular human reproduction.

[89]  J. Gardner,et al.  Estrogen improves TIMP-MMP balance and collagen distribution in volume-overloaded hearts of ovariectomized females. , 2010, American journal of physiology. Regulatory, integrative and comparative physiology.

[90]  A. Roessner,et al.  Role of GPR30 in the mechanisms of tamoxifen resistance in breast cancer MCF-7 cells , 2010, Breast Cancer Research and Treatment.

[91]  N. Joste,et al.  GPR30 and estrogen receptor expression: new insights into hormone dependence of inflammatory breast cancer , 2010, Breast Cancer Research and Treatment.

[92]  E. Prossnitz,et al.  Dilation of Epicardial Coronary Arteries by the G Protein-Coupled Estrogen Receptor Agonists G-1 and ICI 182,780 , 2010, Pharmacology.

[93]  E. Filardo,et al.  The membrane estrogen receptor GPR30 mediates cadmium-induced proliferation of breast cancer cells. , 2010, Toxicology and applied pharmacology.

[94]  A. Salehi,et al.  Activation of G protein-coupled receptor 30 modulates hormone secretion and counteracts cytokine-induced apoptosis in pancreatic islets of female mice , 2010, Molecular and Cellular Endocrinology.

[95]  Laura N. Vandenberg,et al.  Urinary, Circulating, and Tissue Biomonitoring Studies Indicate Widespread Exposure to Bisphenol A , 2010, Environmental health perspectives.

[96]  C. Sobey,et al.  Endothelium-dependent relaxation by G protein-coupled receptor 30 agonists in rat carotid arteries. , 2010, American journal of physiology. Heart and circulatory physiology.

[97]  S. Ho,et al.  Activation of GPR30 inhibits growth of prostate cancer cells via sustained activation of Erk1/2, c-jun/c-fos-dependent upregulation of p21, and induction of G2 cell-cycle arrest , 2010, Cell Death and Differentiation.

[98]  Tudor I. Oprea,et al.  The G protein-coupled receptor GPR30 inhibits proliferation of estrogen receptor-positive breast cancer cells. , 2010, Cancer research.

[99]  S. Anderson,et al.  Estrogen Is Renoprotective via a Nonreceptor-dependent Mechanism after Cardiac Arrest In Vivo , 2010, Anesthesiology.

[100]  Mark D. Huffman,et al.  Heart Disease and Stroke Statistics—2015 Update: A Report From the American Heart Association , 2009, Circulation.

[101]  E. Murphy,et al.  Activation of a novel estrogen receptor, GPER, is cardioprotective in male and female rats. , 2009, American journal of physiology. Heart and circulatory physiology.

[102]  B. Olde,et al.  GPR30/GPER1: searching for a role in estrogen physiology , 2009, Trends in Endocrinology & Metabolism.

[103]  M. Chappell,et al.  Chronic treatment with the G protein-coupled receptor 30 agonist G-1 decreases blood pressure in ovariectomized mRen2.Lewis rats. , 2009, Endocrinology.

[104]  K. Korach,et al.  Importance of Extranuclear Estrogen Receptor-α and Membrane G Protein–Coupled Estrogen Receptor in Pancreatic Islet Survival , 2009, Diabetes.

[105]  Tudor I. Oprea,et al.  In vivo Effects of a GPR30 Antagonist , 2009, Nature chemical biology.

[106]  E. Prossnitz,et al.  Localisation of GPR30, a novel G protein-coupled oestrogen receptor, suggests multiple functions in rodent brain and peripheral tissues , 2009, The Journal of endocrinology.

[107]  Shannon M. Mumenthaler,et al.  17β-Estradiol Prevents Early-Stage Atherosclerosis in Estrogen Receptor-Alpha Deficient Female Mice , 2009, Journal of cardiovascular translational research.

[108]  H. Fuchs,et al.  Expression pattern of G protein-coupled receptor 30 in LacZ reporter mice. , 2009, Endocrinology.

[109]  B. Olde,et al.  The role of the G protein-coupled receptor GPR30 in the effects of estrogen in ovariectomized mice. , 2009, American journal of physiology. Endocrinology and metabolism.

[110]  D. Clegg,et al.  Regulatory role of G protein-coupled estrogen receptor for vascular function and obesity. , 2009, Circulation research.

[111]  B. Olde,et al.  Deletion of the G protein-coupled receptor 30 impairs glucose tolerance, reduces bone growth, increases blood pressure, and eliminates estradiol-stimulated insulin release in female mice. , 2009, Endocrinology.

[112]  B. Komm,et al.  The pairing of a selective estrogen receptor modulator, bazedoxifene, with conjugated estrogens as a new paradigm for the treatment of menopausal symptoms and osteoporosis prevention. , 2008, Endocrinology.

[113]  O. Rønnekleiv,et al.  Modulation of hypothalamic neuronal activity through a novel G-protein-coupled estrogen membrane receptor , 2008, Steroids.

[114]  J. Tanguay,et al.  Local Delivery of 17-Beta-Estradiol Modulates Collagen Content in Coronary Porcine Arteries after PTCA and Stent Implantation , 2008, Journal of Vascular Research.

[115]  Chung Lee,et al.  The proliferative effect of estradiol on human prostate stromal cells is mediated through activation of ERK , 2008, The Prostate.

[116]  Yaling Han,et al.  Estrogen‐eluting stent implantation inhibits neointimal formation and extracellular signal‐regulated kinase activation , 2007, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[117]  L. Sklar,et al.  Synthetic estrogen derivatives demonstrate the functionality of intracellular GPR30. , 2007, ACS chemical biology.

[118]  J. Manson,et al.  Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. , 2007, JAMA.

[119]  Tudor I. Oprea,et al.  G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells. , 2007, Cancer research.

[120]  P. Thomas,et al.  Binding and activation of the seven-transmembrane estrogen receptor GPR30 by environmental estrogens: A potential novel mechanism of endocrine disruption , 2006, The Journal of Steroid Biochemistry and Molecular Biology.

[121]  T. Deuel,et al.  A variant of estrogen receptor-α, hER-α36: Transduction of estrogen- and antiestrogen-dependent membrane-initiated mitogenic signaling , 2006 .

[122]  G. Vollmer,et al.  Hormonal activity of combinations of genistein, bisphenol A and 17β-estradiol in the female Wistar rat , 2006, Archives of Toxicology.

[123]  Tudor I. Oprea,et al.  Virtual and biomolecular screening converge on a selective agonist for GPR30 , 2006, Nature chemical biology.

[124]  T. Deuel,et al.  Identification, cloning, and expression of human estrogen receptor-α36, a novel variant of human estrogen receptor-α66 , 2005 .

[125]  J. Dong,et al.  Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. , 2005, Endocrinology.

[126]  James A. Clark,et al.  Estrogen receptor-β mediates male-female differences in the development of pressure overload hypertrophy , 2005 .

[127]  M. Burnier,et al.  Female sex hormones, salt, and blood pressure regulation. , 2004, American journal of hypertension.

[128]  S. Hulley,et al.  The WHI estrogen-alone trial--do things look any better? , 2004, JAMA.

[129]  J. Manson,et al.  Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial , 2004 .

[130]  R. Stafford,et al.  National use of postmenopausal hormone therapy: annual trends and response to recent evidence. , 2004, JAMA.

[131]  N. Kipshidze,et al.  Estrogen‐eluting, phosphorylcholine‐coated stent implantation is associated with reduced neointimal formation but no delay in vascular repair in a porcine coronary model , 2002, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[132]  B. Nicklas,et al.  Differences in adipose tissue metabolism between postmenopausal and perimenopausal women. , 2002, The Journal of clinical endocrinology and metabolism.

[133]  C. Kooperberg,et al.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.

[134]  J. S. Janicki,et al.  Gender differences in cardiac remodeling secondary to chronic volume overload. , 2002, Journal of cardiac failure.

[135]  K. Korach,et al.  Estrogen receptor α is a major mediator of 17β-estradiol’s atheroprotective effects on lesion size in Apoe–/– mice , 2001 .

[136]  D. Parra,et al.  Estrogen replacement therapy and the prevention of coronary heart disease in postmenopausal women. , 2000, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[137]  K. Bland,et al.  Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. , 2000, Molecular endocrinology.

[138]  J. Bender,et al.  Human vascular endothelial cells contain membrane binding sites for estradiol, which mediate rapid intracellular signaling. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[139]  D. Deecher,et al.  Differential effects of estradiol and estradiol-BSA conjugates. , 1999, Endocrinology.

[140]  J. York,et al.  Estrogen-induced activation of mitogen-activated protein kinase requires mobilization of intracellular calcium. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[141]  P. Shaul.  Rapid activation of endothelial nitric oxide synthase by estrogen , 1999, Steroids.

[142]  P. Douglas,et al.  Hypertrophic remodeling: gender differences in the early response to left ventricular pressure overload. , 1998, Journal of the American College of Cardiology.

[143]  R. Weigel,et al.  Identification of a gene (GPR30) with homology to the G-protein-coupled receptor superfamily associated with estrogen receptor expression in breast cancer. , 1997, Genomics.

[144]  C. Rosenfeld,et al.  Estrogen acutely stimulates nitric oxide synthase activity in fetal pulmonary artery endothelium. , 1997, The American journal of physiology.

[145]  R. Karas,et al.  Estrogen inhibits the vascular injury response in estrogen receptor α-deficient mice , 1997, Nature Medicine.

[146]  P. Bontempo,et al.  Tyrosine kinase/p21ras/MAP‐kinase pathway activation by estradiol‐receptor complex in MCF‐7 cells. , 1996, The EMBO journal.

[147]  S. Oparil,et al.  Estrogen reduces myointimal proliferation after balloon injury of rat carotid artery. , 1996, Circulation.

[148]  S. Manuck,et al.  Dominant social status and contraceptive hormone treatment inhibit atherogenesis in premenopausal monkeys. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[149]  K. Kerlikowske,et al.  Hormone replacement therapy and endometrial cancer risk: a meta-analysis. , 1995, Obstetrics and gynecology.

[150]  B. Katzenellenbogen,et al.  Estrogen action via the cAMP signaling pathway: stimulation of adenylate cyclase and cAMP-regulated gene transcription. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[151]  S. Manuck,et al.  Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys. Lack of an effect of added progesterone. , 1990, Arteriosclerosis.

[152]  R. Pietras,et al.  Specific binding sites for oestrogen at the outer surfaces of isolated endometrial cells , 1977, Nature.

[153]  J. Davis,et al.  Adenosine 3',5'-monophosphate in rat uterus: acute elevation by estrogen. , 1967, Proceedings of the National Academy of Sciences of the United States of America.

[154]  Dong Li,et al.  Differential expression of G-protein-coupled estrogen receptor-30 in human myometrial and uterine leiomyoma smooth muscle. , 2013, Fertility and sterility.

[155]  A. Shapiro,et al.  Islet transplantation in type 1 diabetes: ongoing challenges, refined procedures, and long-term outcome. , 2012, The review of diabetic studies : RDS.

[156]  E. Stefani,et al.  A novel estrogen receptor GPER inhibits mitochondria permeability transition pore opening and protects the heart against ischemia-reperfusion injury. , 2010, American journal of physiology. Heart and circulatory physiology.

[157]  Heidrun Kern,et al.  GPR30 Does Not Mediate Estrogenic Responses in Reproductive Organs in Mice , 2009, Biology of reproduction.

[158]  L. Ballesteros,et al.  Binding of 17-β-estradiol to the outer surface and nucleus of human spermatozoa , 1979 .